Harbour BioMed inks $350 million deal for rights to A167
Member News

Related or similar articles

May 17, 2024
Streamlining Procurement: Labshares Partners with Labviva for Enhanced Access and Efficiency
In the fast-paced world of biotech innovation, easy access to crucial resources is vital for research success. That's why Labshares is excited to share news of our partnership with Labviva, a top procurement platform reshaping how scientists obtain l
Labshares News